Hematology-Oncology390

Pub YearTitleAuthor(s)
2015Mutations in the Spliceosomal Machinery Genes SRSF2, U2AF1, and ZRSR2 and Response to Decitabine in Myelodysplastic Syndrome.박준성
2024Neoadjuvant–adjuvant pertuzumab in HER2-positive early breast cancer: final analysis of the randomized phase III PEONY trial강석윤
2010New drugs in hematological disorders박준성, 정성현
2018OA10.05: An Open-Label, Multicenter, Phase II Single Arm Trial of Osimertinib in NSCLC Patients with Uncommon EGFR Mutation(KCSG-LU15-09)이현우
2024Open-Label, Multicenter, Randomized, Biomarker-Integrated Umbrella Trial for Second-Line Treatment of Advanced Gastric Cancer: K-Umbrella Gastric Cancer Study이현우
2020Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia박준성
2015Oral Maintenance Chemotherapy with 6-Mercaptopurine and Methotrexate in Patients with Acute Myeloid Leukemia Ineligible for Transplantation.강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁
2020Osimertinib for Patients With Non-Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09)안미선
2009Outcome of Locally Advanced Esophageal Cancer Treated with Concurrent Chemo-radiotherapy강석윤, 강승희, 오영택, 전미선, 최진혁
2023Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts정성현, 최윤석
1996Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.최진혁
2022Oxaliplatin (3 months v 6 months) with 6 Months of Fluoropyrimidine as Adjuvant Therapy in Patients with Stage II/III Colon Cancer: KCSG CO09-07강석윤
2018P1.15-14: Pneumonia in Patients with Lung Cancer of South Korea: A Nationwide Population Based Study이현우, 정준호, 허재성
2023p15INK4B is an alternative marker of senescent tumor cells in colorectal cancer김영화, 김장희, 박태준, 신준상, 이영경, 임수빈, 최용원
2018P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study최진혁
2019Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial강석윤
1995Patency of a small vessel prosthesis bonded to tissue plasminogen activator and iloprost.김효철
2012Pathologic diagnosis of recurrent glioblastoma: morphologic, immunohistochemical, and molecular analysis of 20 paired cases김보영, 김세혁, 김영배, 김장희, 신승수, 이기범, 이현우, 정선용, 한재호
2018Patient's Cognitive Function and Attitudes towards Family Involvement in Cancer Treatment Decision Making: A Patient-Family Caregiver Dyadic Analysis이현우
2020Patient-Reported Outcomes of Palbociclib Plus Exemestane with GnRH Agonist versus Capecitabine in Premenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer: A Prospective, Open-Label, Randomized Phase ll Trial (KCSG-BR 15-10)강석윤

Browse